Domperidone tied to modest increase in breast milk supply

Domperidone tied to modest increase in breast milk supply

(HealthDay)—Domperidone is well tolerated and effective in producing a moderate short-term increase in expressed breast milk volume among mothers of preterm infants, according to a review published online Feb. 22 in BJOG: An International Journal of Obstetrics and Gynaecology.

Luke E. Grzeskowiak, Ph.D., from the University of Adelaide in Australia, and colleagues conducted a literature review to identify that compared domperidone with placebo in of preterm infants (<37 weeks' gestation) experiencing insufficient milk supply.

The researchers identified five trials consisting of 194 women. Pooled analysis showed a moderate increase in breast milk volume of 88.3 mL/day with the use of domperidone versus placebo. Maternal adverse events were similar between the groups (odds ratio, 1.05; 95 percent confidence interval, 0.65 to 1.71), with no reported cases of prolonged QTc syndrome or sudden cardiac death.

"Domperidone is well tolerated and results in a moderate short-term increase in expressed breast milk volume among mothers of previously identified as having insufficient breast milk supply," the authors write.


Explore further

Controversial medication has benefits for breastfeeding

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2018 HealthDay. All rights reserved.

Citation: Domperidone tied to modest increase in breast milk supply (2018, March 5) retrieved 13 October 2019 from https://medicalxpress.com/news/2018-03-domperidone-tied-modest-breast.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more